lisocabtagene maraleucel,axicabtagene ciloleucel
bms,daiichi sankyo,gilead
['dlbcl', 'transform,(-transformi),(-transforme),(-transforma),(-transforms),(-transform1),(-transform 1),(-transform-1),(-transform2),(-transform 2),(-transform-2)', 'zuma-7', ' elo ']
#ash22 outcomes of dlbcl in patients achieving cr after r-ice: refractory and early relapse &lt;12 mo patients achieving cr may achieve lt disease control with asct (2/3) 
Adult BMT & Cellular Therapy @MountSinaiNYC @TischCancer Founder: https://t.co/LFdHmTq9L3… Passion for #bmt #cart #photography #poetry ????? ??